Increased ACE2 levels, associated with a decrease in AngII due to conversion into Ang 1–7, is typically considered an indicator of organ protection because of its role in reducing pulmonary vasoconstriction, remodeling, atherosclerosis, blood pressure, myocardial hypertrophy, fibrosis and ventricular remodeling. Here, ACE2 is linked to atherosclerosis.